Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and moderate renal impairment: a pooled analysis of three clinical trials

DSpace Repository

Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and moderate renal impairment: a pooled analysis of three clinical trials

Author: Siegel, David S.; Weisel, Katja C.; Dimopoulos, Meletios A.; Baz, Rachid; Richardson, Paul; Delforge, Michel; Song, Kevin W.; San Miguel, Jesus F.; Moreau, Philippe; Goldschmidt, Hartmut; Cavo, Michele; Jagannath, Sundar; Yu, Xin; Hong, Kevin; Sternas, Lars; Zaki, Mohamed; Palumbo, Antonio
Tübinger Autor(en):
Weisel, Katja
Published in: Leukemia & Lymphoma (2016), Bd. 57, H. 12, S. 2833-2838
Verlagsangabe: Taylor & Francis Ltd
Language: English
Full text: http://dx.doi.org/10.1080/10428194.2016.1177181
ISSN: 1029-2403
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)